Dan Peer

Dan Peer is a professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Vice Dean for Research at the George S. Wise Faculty of Life Sciences as well as the Founder and Managing Director of the SPARK Tel Aviv, Center for Translational Medicine. Additionally, since 2016 he is the Chair of Tel Aviv University Cancer Biology Research Center.[1] Peer holds more than 120 pending and granted patents.

Peer is a scientific advisory board member in more than 10 companies and on the scientific advisory board of 15 journals. He is a past President of the Israeli Chapter of the Controlled Release Society,[2] and a Past Member of the Board of the Israel Young Academy of Science.[3]

Research work

Peer's work was among the first to demonstrate immunomodulation through a systemic delivery of RNA-loaded targeted nanocarriers. He pioneered the use of RNAi to reprogram immune cells and discover new therapeutic modalities.[4] In addition, his lab was the first to show systemic, cell specific delivery of modified mRNA to cells. Through this method they have induced therapeutic gene expression of desired proteins within the immune system, which has enormous implications in cancer and inflammation.[5][6]

Research focus

The Peer lab is designing novel methodologies to manipulate cells' function in vivo, using targeted, safe, lipid nanoparticles. They are utilizing nanotechnology tools to generate novel therapeutic strategies for inflammatory diseases and cancers.[7] The lab is combining multidisciplinary approaches including immunology, cell and molecular biology, genetics, protein engineering, material sciences, nanotechnology and computational techniques for drug discovery. In addition, they are designing highly selective targeted nanocarriers able to reprogram cells in a discerning manner, with an ultimate goal to translate the findings into clinical settings.[8][9][10]

Awards
  • 2008 Alon fellowship for outstanding young researchers, awarded by the Israeli Ministry of Education.
  • The 2010 Innovator award in Inflammatory Bowel Disease from the Kenneth Rainin Foundation (CA, USA)[11]
  • Innovator Award on Cancer strategy (The inaugural Untold News Award, 2014)[12]
  • 2013 Breakthrough Award from the Kenneth Rainin Foundation[13]
gollark: I'm actually now writing useful and extensive API docs for PotatOS. What has the world come to?
gollark: [EXPUNGEMENT EXPUNGED]
gollark: Antiexpungement cognitomemes.
gollark: Replying to <@309787486278909952> from https://discord.com/channels/346530916832903169/348702212110680064/746772693746974781If you actually *find* them conveniently, and don't just end up wit hrandom corruption somewhere.
gollark: We no longer deploy [DATA EXPUNGED].

References
  1. "Dan Peer Lab, Tel Aviv University - Prof. Dan Peer". Tel Aviv University.
  2. "Dan Peer". Controlled Release Society (CRS).
  3. "TAU professor appointed to Young Academy of Science". Tel Aviv University.
  4. "Beyin kanseri tedavisinde büyük buluş". Şalom (in Turkish).
  5. "New platform based on biology and nanotechnology carries mRNA directly to target cells". Phys.org.
  6. "TAU sets up translational medical research center". Globes (in Hebrew). 30 January 2018.
  7. Shamah, David. "Nano-bullet tech shoots down brain cancer in Tel Aviv U study". The Times of Israel.
  8. Arnold, Janice (5 March 2019). "Cannabis to treat cancer? Israeli scientist thinks so". The Canadian Jewish News.
  9. "Dan Peer: "Mi trabajo es ciencia ficción: trato de hacer realidad ideas locas "". La Nación (in Spanish). 19 August 2019.
  10. "Researchers divided on future of cannabis as a whole plant or isolated medicine". Daily Hive.
  11. "The Kenneth Rainin Foundation 2010 Innovator Awards". Kenneth Rainin Foundation.
  12. Sarah, Viva (4 December 2014). "Three Israeli inventors win Untold News Awards for thinking out of the box". ISRAEL21c.
  13. "Recipients 2013". Kenneth Rainin Foundation.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.